Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.800
+0.040 (5.26%)
At close: Mar 10, 2026
-15.79%
Market Cap 690.88M
Revenue (ttm) 2.20B
Net Income (ttm) 22.52M
Shares Out 863.60M
EPS (ttm) 0.02
PE Ratio 35.01
Forward PE n/a
Dividend 0.05 (6.58%)
Ex-Dividend Date May 23, 2025
Volume 413,000
Average Volume 440,150
Open 0.750
Previous Close 0.760
Day's Range 0.740 - 0.800
52-Week Range 0.500 - 1.000
Beta 0.55
RSI 59.92
Earnings Date Mar 25, 2026

About HKG:3737

Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. The company operates through Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It also provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brand names. In addition, the company manufactures and sells food and Chinese herbs; offers detection and testing services; and manages properties. Fu... [Read more]

Sector Healthcare
Founded 1993
Employees 2,488
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3737
Full Company Profile

Financial Performance

In 2024, HKG:3737's revenue was 2.21 billion, an increase of 8.05% compared to the previous year's 2.05 billion. Earnings were 95.21 million, a decrease of -41.51%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.